Last reviewed · How we verify

NCT05138107

Prospective Placebo-controlled Study of Synochi Scar Spray

Status unknown NA Last updated 16 June 2022
What this trial tests

NA trial testing Synochi Scar Spray Cosmetic in Burns Multiple in 28 participants. Status unknown.

Timeline
1 July 2022
Primary endpoint
17 May 2024
17 July 2025

Quick facts

Lead sponsorSynochi, LLC
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingtriple
Primary purposesupportive care
Enrollment28
Start date1 July 2022
Primary completion17 May 2024
Estimated completion17 July 2025

Drugs / interventions tested

Conditions studied

Sponsor

Synochi, LLC

Who can join

Adults 22 to 50, any sex, with Burns Multiple. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Randomized, double-blind, placebo controlled, prospective, split-scar study of severe burn victims with autologous skin transplants. 9 months intervention time and 3 months follow-up, photographic scar documentation, self-and observer questionnaires throughout

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Burns Multiple

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05138107.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing